Moving forward with a transition that has been in the works for several months, Pernix Therapeutics Holdings Inc. NASDAQ:PTX) has added a $65 million investment, settled some legal issues and named a new high-profile CEO. As a result, the company’s stock price has surged. Pernix Therapeutics Holdings Inc (NASDAQ:PTX) stock opened at $2.36 in last session, and closed at $3.53, while the day range of PTX stock is $2.32 – $3.89. The stock showed a positive weekly performance of 50.21%.
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) announced the pricing of an underwritten public offering of 6,841,250 shares of common stock for a public offering price of $4.00 per share, and pre-funded warrants to purchase up to an aggregate of 2,158,750 shares of common stock at the per share public offering price for the common stock less the $0.01 per share exercise price for each such pre-funded warrant. Idera Pharmaceuticals Inc (NASDAQ:IDRA) stock opened at $4.04, in last session and closed at $4.56, by gaining 8.57%. The 52 week range of IDRA is $0.19 – $5.55. Company’s market capitalization is $213.07million.
Sarepta Therapeutics Inc (NASDAQ:SRPT) Eteplirsen treatment for Duchenne muscular dystrophy demonstrates stability on pulmonary function tests through 120 Weeks in a Phase IIb Study of twelve boys aged 7-13 years. Sarepta Therapeutics Inc (NASDAQ:SRPT) stock advanced 9.45% and finished the last session at $25.13. The EPS of the stock remained -5.52. Company’s market capitalization is $944.44million.
Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) rose 8.04% early Wednesday after a SA blog post was bullish on the stock. Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) stock opened the session at $16.91, and closed the session at $16.21. The 52 week range of the ORMP stock remained $5.00 – $31.73 and the day range was $15.76 – $18.95.